Primo Chemicals Ltd. carries a market capitalization of 5.44B, placing it among publicly traded companies globally. Its enterprise value stands at 5.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.44B |
| Enterprise Value | 5.71B |
Primo Chemicals Ltd. currently has 242.34M shares outstanding.
| Shares Outstanding | 242.34M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Primo Chemicals Ltd. trades at a trailing price-to-earnings ratio of 29.28. The price-to-sales ratio is 0.80, and the price-to-book ratio stands at 9.29.
| PE Ratio | 29.28 |
| PS Ratio | 0.80 |
| PB Ratio | 9.29 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Primo Chemicals Ltd. trades at an EV/EBITDA multiple of 36.29 and an EV/FCF ratio of 49.13. The EV/Sales ratio of 1.02 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 36.29 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.02 |
| EV / EBITDA | 36.29 |
| EV / EBIT | 36.29 |
| EV / FCF | 49.13 |
Primo Chemicals Ltd. maintains a current ratio of 0.56, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.29, indicating elevated leverage, while an interest coverage ratio of 0.85 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.56 |
| Quick Ratio | 0.06 |
| Debt / Equity | 32.29 |
| Debt / EBITDA | 8.34 |
| Interest Coverage | 0.85 |
Primo Chemicals Ltd. posts a return on equity of 12.58 and a return on invested capital of 1.80.
| Return on Equity (ROE) | 12.58 |
| Return on Assets (ROA) | 2.15 |
| Return on Invested Capital (ROIC) | 1.80 |
| Return on Capital Employed (ROCE) | 9.91 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 10.68 |
Over the trailing twelve months, Primo Chemicals Ltd. has paid 62.59M in income taxes, reflecting an effective tax rate of 37.21.
| Income Tax | 62.59M |
| Effective Tax Rate | 37.21 |
Primo Chemicals Ltd.'s stock has declined approximately -11.83176% over the past 52 weeks. The 50-day moving average sits at 22.41, while the 200-day moving average is 22.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.83176% |
| 50-Day Moving Average | 22.41 |
| 200-Day Moving Average | 22.73 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Primo Chemicals Ltd. generated 5.62B in revenue and converted that into 153.71M in net income, yielding earnings per share of 0.47. EBITDA reached 157.21M, while operating income came in at 157.21M.
| Revenue | 5.62B |
| Gross Profit | 2.04B |
| Operating Income | 157.21M |
| Pretax Income | 168.21M |
| Net Income | 153.71M |
| EBITDA | 157.21M |
| EBIT | 157.21M |
| Earnings Per Share (EPS) | 0.47 |
Primo Chemicals Ltd. holds 107.08M in cash and equivalents against 1.31B in total debt, resulting in a net debt position of 1.30B. Total book value stands at 484.69M, with working capital of -856.00M providing operational flexibility.
| Cash & Cash Equivalents | 107.08M |
| Total Debt | 1.31B |
| Net Debt | 1.30B |
| Equity (Book Value) | 484.69M |
| Book Value Per Share | 1.96 |
| Working Capital | -856.00M |
Primo Chemicals Ltd. operates with a gross margin of 36.38, reflecting its pricing power and cost economics. The operating margin of 2.80 and net profit margin of 2.74 provide insight into operational efficiency.
| Gross Margin | 36.38 |
| Operating Margin | 2.80 |
| Pretax Margin | 2.99 |
| Profit Margin | 2.74 |
| EBITDA Margin | 2.80 |
Primo Chemicals Ltd. posts an Altman Z-Score of 1.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.68 |